Skip to content

Building launch readiness beyond the playbook

Turning a regional launch framework into affiliate-specific action across a new therapeutic area

The why

As the client’s regional office prepared to launch a novel asset in a new therapeutic area, it faced a familiar problem in an unfamiliar category. The asset brought high expectations, but affiliates were entering a new therapeutic context with uneven experience, evolving market dynamics, and limited precedent around how to prepare for launch in practice. The region needed a clear view of where readiness was strong, where risk was building, and what had to change before launch plans became execution reality.

The challenge

The client did not lack launch materials, frameworks, or playbooks. It lacked a reliable view of whether affiliates were truly ready to execute. In a complex and novel setting readiness depended on more than completing templates or following a regional playbook. Affiliates differed in market understanding, cross-functional preparedness, and ability to translate strategy into local action. Without a sharper diagnosis, the region risked moving forward with false confidence, uneven execution, and late discovery of critical gaps close to launch.

How we helped

Biobridge Partners designed and executed a two-phased readiness assessment, tailored to local realities across affiliates.

Phase 1: We benchmarked each affiliate’s market understanding and preparedness, identifying gaps to be addressed ahead of launch.

Phase 2: We closed these gaps through targeted market research and in-depth engagement with affiliate teams, validating barriers and opportunities in real time.

Outcome

What moved the needle

The region gained a clearer and more credible view of where launch readiness was strong, where it was weak, and where intervention would change execution before launch. That shifted the conversation from playbook completion to affiliate-specific action and regional prioritisation. What moved the needle was the decision to assess readiness through actual market understanding, local constraints, and execution confidence rather than document status alone. That gave the client a more realistic basis for launch planning and stronger alignment between regional intent and affiliate action.

Partner

Jonas T. Karlsen, Ph.D.

Jonas is a life science strategist supporting executives drive progress across the value chain. He is an expert in bridging strategy and execution via global operating model design and transformation rooted in strategic objectives. He engages with structured top-down thinking and a pragmatic and collaborative approach to mobilise organizations and make things happen.

Jonas holds a Ph.D. in biophysics from the Technical University of Denmark, DTU, and further studied at California Institute of Technology. Recipient of the Ministry of Sciences Elite Research Award.

Selected experience

  • Ecosystem integration and external innovation pipeline
  • Lab of the future capability building and operating model design
  • Global clinical operating model design and transformation
  • Pre-launch strategy for cardiometabolic TA development

 

team-portrait-jonas-tobias-karlsen-4x5-1200x1500